Nifty
:
23850.90
Sensex
:
78782.24
-453.45 (-1.87%)
-606.82 (-0.76%)
Nifty
Sensex
:
:
23850.90
78782.24
-453.45 (-1.87%)
-606.82 (-0.76%)

Sakar Healthcare Ltd.

Pharmaceuticals & Drugs

Rating :
N/A

BSE: Not Listed | NSE: SAKAR

NSE BSE
317.60
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  317.80
  •  323.75
  •  316.00
  •  317.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  17359
  •  55.38
  •  479.00
  •  295.15

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 672.07
  • 54.19
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 745.70
  • N/A
  • 2.54

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 53.15%
  • 4.45%
  • 16.87%
  • FII
  • DII
  • Others
  • 13.42%
  • 0.00%
  • 12.11%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.91
  • 13.07
  • 6.14

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.17
  • 14.45
  • 5.52

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 20.29
  • 3.94
  • -8.39

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 36.41

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 2.75

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 16.27

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
42.78
34.08
25.53%
41.15
38.99
5.54%
43.06
40.65
5.93%
37.23
33.46
11.27%
Expenses
31.28
24.72
26.54%
30.45
29.96
1.64%
32.09
32.87
-2.37%
28.22
24.66
14.44%
EBITDA
11.50
9.36
22.86%
10.70
9.03
18.49%
10.97
7.78
41.00%
9.01
8.80
2.39%
EBIDTM
26.89%
27.46%
26.00%
23.15%
25.47%
19.15%
24.20%
26.30%
Other Income
0.37
0.66
-43.94%
0.46
1.52
-69.74%
0.77
1.82
-57.69%
0.23
1.85
-87.57%
Interest
1.64
1.65
-0.61%
1.40
2.08
-32.69%
2.08
2.15
-3.26%
1.79
1.94
-7.73%
Depreciation
5.12
4.22
21.33%
5.06
4.52
11.95%
4.87
3.55
37.18%
4.45
4.10
8.54%
PBT
5.11
4.15
23.13%
4.70
3.95
18.99%
4.80
3.89
23.39%
3.00
4.61
-34.92%
Tax
0.32
0.52
-38.46%
2.29
1.11
106.31%
1.67
-0.03
-
0.93
0.60
55.00%
PAT
4.80
3.64
31.87%
2.41
2.84
-15.14%
3.12
3.92
-20.41%
2.07
4.01
-48.38%
PATM
11.21%
10.67%
5.86%
7.29%
7.25%
9.65%
5.57%
11.99%
EPS
2.21
1.70
30.00%
1.11
1.49
-25.50%
1.43
2.06
-30.58%
0.95
2.16
-56.02%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Net Sales
164.22
153.35
133.36
128.23
94.74
82.98
Net Sales Growth
11.58%
14.99%
4.00%
35.35%
14.17%
 
Cost Of Goods Sold
90.61
83.67
73.54
74.42
51.11
43.05
Gross Profit
73.61
69.67
59.81
53.80
43.63
39.93
GP Margin
44.82%
45.43%
44.85%
41.96%
46.05%
48.12%
Total Expenditure
122.04
114.96
100.09
98.89
72.13
63.43
Power & Fuel Cost
-
4.25
2.90
3.01
2.26
3.31
% Of Sales
-
2.77%
2.17%
2.35%
2.39%
3.99%
Employee Cost
-
18.82
15.81
14.26
12.74
11.61
% Of Sales
-
12.27%
11.86%
11.12%
13.45%
13.99%
Manufacturing Exp.
-
1.34
0.81
1.24
1.20
1.64
% Of Sales
-
0.87%
0.61%
0.97%
1.27%
1.98%
General & Admin Exp.
-
4.22
3.65
3.43
2.87
2.68
% Of Sales
-
2.75%
2.74%
2.67%
3.03%
3.23%
Selling & Distn. Exp.
-
2.17
3.06
2.38
1.33
1.10
% Of Sales
-
1.42%
2.29%
1.86%
1.40%
1.33%
Miscellaneous Exp.
-
0.49
0.32
0.15
0.61
0.04
% Of Sales
-
0.32%
0.24%
0.12%
0.64%
0.05%
EBITDA
42.18
38.39
33.27
29.34
22.61
19.55
EBITDA Margin
25.69%
25.03%
24.95%
22.88%
23.87%
23.56%
Other Income
1.83
3.18
4.67
2.17
1.18
2.02
Interest
6.91
7.62
5.96
2.91
2.49
2.26
Depreciation
19.50
18.05
14.99
9.67
8.06
7.08
PBT
17.61
15.90
16.99
18.93
13.23
12.23
Tax
5.21
4.23
4.23
3.75
2.55
2.60
Tax Rate
29.59%
26.60%
24.90%
19.81%
19.27%
21.26%
PAT
12.40
11.67
12.76
15.18
10.68
9.62
PAT before Minority Interest
12.40
11.67
12.76
15.18
10.68
9.62
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
7.55%
7.61%
9.57%
11.84%
11.27%
11.59%
PAT Growth
-13.95%
-8.54%
-15.94%
42.13%
11.02%
 
EPS
5.71
5.38
5.88
7.00
4.92
4.43

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Shareholder's Funds
262.33
173.35
127.45
98.45
81.32
Share Capital
21.75
19.04
17.12
15.62
14.96
Total Reserves
235.78
154.31
110.33
82.83
66.36
Non-Current Liabilities
67.27
108.50
93.54
46.07
19.57
Secured Loans
52.30
93.17
79.93
35.04
8.79
Unsecured Loans
2.65
5.05
5.07
3.41
3.68
Long Term Provisions
2.29
1.70
1.44
0.79
0.70
Current Liabilities
59.06
54.49
46.78
33.27
14.15
Trade Payables
27.45
26.09
30.50
19.78
5.44
Other Current Liabilities
16.30
13.58
8.57
8.82
4.98
Short Term Borrowings
13.88
13.02
4.52
1.69
2.18
Short Term Provisions
1.43
1.80
3.19
2.97
1.55
Total Liabilities
388.66
336.34
267.77
177.79
115.04
Net Block
314.29
266.64
204.65
69.10
65.69
Gross Block
370.69
304.99
235.50
90.28
78.81
Accumulated Depreciation
56.40
38.35
30.84
21.18
13.12
Non Current Assets
317.05
280.42
217.74
144.07
93.46
Capital Work in Progress
0.32
6.45
1.23
48.92
13.10
Non Current Investment
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
2.44
7.33
11.86
26.05
14.68
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
Current Assets
71.61
55.92
50.02
33.72
21.58
Current Investments
0.00
3.43
7.11
0.00
0.00
Inventories
27.73
15.40
14.18
15.70
10.93
Sundry Debtors
20.91
22.08
14.18
12.37
8.23
Cash & Bank
0.47
0.09
0.03
0.08
0.30
Other Current Assets
22.50
0.46
0.22
0.09
2.12
Short Term Loans & Adv.
21.65
14.46
14.30
5.48
2.04
Net Current Assets
12.55
1.42
3.25
0.45
7.42
Total Assets
388.66
336.34
267.76
177.79
115.04

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Cash From Operating Activity
24.47
33.34
35.70
14.58
18.86
PBT
15.90
16.88
18.93
13.23
12.23
Adjustment
24.90
20.14
12.50
8.90
9.19
Changes in Working Capital
101.03
0.60
4.09
-6.83
0.22
Cash after chg. in Working capital
141.83
37.61
35.52
15.30
21.64
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
-117.36
-4.27
0.18
-0.73
-2.77
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-51.54
-74.38
-90.37
-46.83
-22.41
Net Fixed Assets
-59.57
-74.71
-97.53
-47.29
Net Investments
3.43
3.68
-7.11
0.00
Others
4.60
-3.35
14.27
0.46
Cash from Financing Activity
27.44
41.10
54.62
32.03
3.48
Net Cash Inflow / Outflow
0.37
0.06
-0.05
-0.22
-0.06
Opening Cash & Equivalents
0.09
0.03
0.08
0.31
0.37
Closing Cash & Equivalent
0.47
0.09
0.03
0.08
0.31

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Book Value (Rs.)
118.41
91.04
74.45
63.04
54.35
ROA
3.22%
4.22%
6.81%
7.30%
8.36%
ROE
5.42%
8.48%
13.44%
11.88%
11.83%
ROCE
7.42%
8.95%
12.09%
13.16%
14.79%
Fixed Asset Turnover
0.45
0.49
0.79
1.12
1.05
Receivable days
51.16
49.62
37.80
39.70
36.22
Inventory Days
51.33
40.48
42.53
51.30
48.09
Payable days
116.77
140.43
123.30
90.05
46.13
Cash Conversion Cycle
-14.29
-50.33
-42.97
0.95
38.18
Total Debt/Equity
0.31
0.69
0.73
0.43
0.20
Interest Cover
3.09
3.85
7.51
6.30
6.41

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Sakar Healthcare - Quarterly Results
    22nd Oct 2024, 12:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.